Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug;1449(1):3-24.
doi: 10.1111/nyas.14129. Epub 2019 Jun 10.

Alzheimer's disease and symbiotic microbiota: an evolutionary medicine perspective

Affiliations
Review

Alzheimer's disease and symbiotic microbiota: an evolutionary medicine perspective

Molly Fox et al. Ann N Y Acad Sci. 2019 Aug.

Abstract

Microorganisms resident in our bodies participate in a variety of regulatory and pathogenic processes. Here, we describe how etiological pathways implicated in Alzheimer's disease (AD) may be regulated or disturbed by symbiotic microbial activity. Furthermore, the composition of symbiotic microbes has changed dramatically across human history alongside the rise of agriculturalism, industrialization, and globalization. We postulate that each of these lifestyle transitions engendered progressive depletion of microbial diversity and enhancement of virulence, thereby enhancing AD risk pathways. It is likely that the human life span extended into the eighth decade tens of thousands of years ago, yet little is known about premodern geriatric epidemiology. We propose that microbiota of the gut, oral cavity, nasal cavity, and brain may modulate AD pathogenesis, and that changes in the microbial composition of these body regions across history suggest escalation of AD risk. Dysbiosis may promote immunoregulatory dysfunction due to inadequate education of the immune system, chronic inflammation, and epithelial barrier permeability. Subsequently, proinflammatory agents-and occasionally microbes-may infiltrate the brain and promote AD pathogenic processes. APOE genotypes appear to moderate the effect of dysbiosis on AD risk. Elucidating the effect of symbiotic microbiota on AD pathogenesis could contribute to basic and translational research.

Keywords: Alzheimer's disease; dementia; evolutionary medicine; immunoregulation; microbiome.

PubMed Disclaimer

Conflict of interest statement

Competing interests

The authors declare no competing interests.

Figures

Figure 1.
Figure 1.
Over the past 15,000 years of human history, there have been a series of major lifestyle transitions that comprised changes in demography, environments, subsistence, and epidemiology. These transitions also likely brought about major changes in the composition of symbiotic microbiota, including generally reduced diversity and enhanced pathogenic virulence. Suppositions regarding pre-Agricultural Revolution gut flora are based on analyses comparing the gut microbial compositions of contemporary people who practice hunting–gathering subsistence strategies in nonindustrialized communities in Tanzania (Hadza), Peru (Matses), Malawi, and Venezuela, and fossil assemblages of Neanderthals (compilation from Spain, Croatia, Germany, and Russia), Denisovans (from Siberia), and other early hominins (from Spain) with those of contemporary industrialized populations in Europe, North America, Asia, and Oceania. We note that contemporary hunter–gatherers offer an imperfect proxy for premodern gut microbiomes.
Figure 2.
Figure 2.
Biomechanisms by which symbiotic microbiota in various regions of the human body may affect Alzheimer’s disease pathogenic processes.

Similar articles

Cited by

References

    1. Rook GAW 2010. 99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: Darwinian medicine and the ‘hygiene’ or ‘old friends’ hypothesis. Clin. Exp. Immunol 160: 70–79. - PMC - PubMed
    1. Lai KSP, Liu CS, Rau A, et al. 2017. Peripheral inflammatory markers in Alzheimer’s disease: a systematic review and meta-analysis of 175 studies. J. Neurol. Neurosurg. Psychiatry 88: 876–882. - PubMed
    1. Schmidt R, Schmidt H, Curb JD, et al. 2002. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia aging study. Ann. Neurol 52: 168–174. - PubMed
    1. Fox M, Knapp LA, Andrews PW, et al. 2013. Hygiene and the world distribution of Alzheimer’s disease. Evol. Med. Public Health 2013: 173–186. - PMC - PubMed
    1. Vogt NM, Kerby RL, Dill-McFarland KA, et al. 2017. Gut microbiome alterations in Alzheimer’s disease. Sci. Rep 7: 13537. - PMC - PubMed

Publication types